Periodic Reporting for period 1 - Multiple Sclerosis (Development of a Functionalised Biomaterial Scaffold to Treat Multiple Sclerosis)

Multiple sclerosis (MS) is a chronic debilitating demyelinating disease of the central nervous system (CNS) which affects over 700,000 people in Europe with a total annual health care cost of €27.3 billion (Ernstsson et al., 2016). Current therapeutic strategies offer...